Researchers reported long-term remission of HIV-1 in a patient who received an allogeneic hematopoietic stem cell transplant from a sibling donor carrying the CCR5Δ32/Δ32 mutation. Published in Nature Microbiology, the case adds clinical weight to CCR5-based strategies where donor cells confer resistance to HIV entry, providing a benchmark for long-term remission research.